l 694,458 has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Fujiwara, H; Furukawa, T; Hata, M; Hayakawa, Y; Hayata, Y; Hirata, Y; Kinoshita, H; Koike, K; Kon, S; Konishi, M; Kurokawa, K; Muranishi, Y; Nakagawa, H; Oya, Y; Tateishi, K; Tomita, H; Tsuboi, M; Wang, TC; Worthley, DL | 1 |
| Goldenring, JR; Lapierre, LA; Manning, EH; Mills, JC | 1 |
| Ameen, NA; Finke, PE; Fox, JG; Goldenring, JR; LaFleur, BJ; Nam, KT; Sousa, JF; Weis, JA; Weis, VG | 1 |
| Car, BD; Goldenring, JR; Nomura, S; Ogawa, M | 1 |
| Barnes, TB; Car, BD; Coffey, RJ; Goldenring, JR; Haley, PJ; Meunier, PC; Ray, GS | 1 |
6 other study(ies) available for l 694,458 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
GPR30-Expressing Gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia.
Topics: Animals; Azetidines; Cell Communication; Cell Differentiation; Cell Lineage; Chief Cells, Gastric; Dichloroacetic Acid; Disease Models, Animal; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Intercellular Signaling Peptides and Proteins; Metaplasia; Mice; Mice, Knockout; Piperazines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Receptors, Estrogen; Receptors, G-Protein-Coupled; Stem Cells; Tamoxifen | 2020 |
Tamoxifen Acts as a Parietal Cell Protonophore.
Topics: Animals; Atrophy; Azetidines; Cells, Cultured; Disease Models, Animal; Humans; Hydrogen-Ion Concentration; Metaplasia; Parietal Cells, Gastric; Piperazines; Precancerous Conditions; Primary Cell Culture; Protons; Rabbits; Tamoxifen | 2020 |
Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
Topics: Animals; Azetidines; Biomarkers; Clusterin; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Helicobacter Infections; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Intestines; Laser Capture Microdissection; Metaplasia; Mice; Mice, Inbred CFTR; Parietal Cells, Gastric; Peptides; Piperazines; Precancerous Conditions; Up-Regulation | 2013 |
Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777.
Topics: Analysis of Variance; Animals; Azetidines; Disease Models, Animal; Drug Interactions; Gastric Acid; Gastric Mucosa; Gastritis, Atrophic; Immunohistochemistry; Male; Omeprazole; Parietal Cells, Gastric; Piperazines; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Trefoil Factor-2 | 2006 |
Reversible drug-induced oxyntic atrophy in rats.
Topics: Acridine Orange; Aminopyrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atrophy; Azetidines; Carbon Radioisotopes; Disease Models, Animal; Enzyme Inhibitors; Fluorescent Dyes; Gastric Acid; Gastrins; Gastritis; H(+)-K(+)-Exchanging ATPase; Ionophores; Leukocyte Elastase; Male; Necrosis; Nigericin; Parietal Cells, Gastric; Piperazines; Rabbits; Rats; Rats, Sprague-Dawley; Regeneration; Stomach | 2000 |